Darren M. Brenner, MD, FACG

Northwestern University Feinberg School of Medicine

Poster(s):

• A0089 - Naloxegol Provides Clinically Meaningful Healthcare-Related Quality of Life (HR-QoL) Improvement (PAC-QOL) in Patients With Opioid-Induced Constipation (OIC): A Pooled Analysis of Two Global Phase 3 Studies of Naloxegol
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET

• A0090 - Naloxegol Provides Clinically Meaningful Symptom Improvement (PAC-SYM) in Patients With Opioid-Induced Constipation (OIC): A Pooled Analysis of Two Global Phase 3 Studies of Naloxegol
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET